Clinical-Stage Biopharma w/ a Novel Target Therapy - Business for Sale
Request Information
The contact information for this deal is locked. If you wish to unlock this information, you need to upgrade to SMB Deal Hunter Pro.
💊
Clinical-Stage Biopharma Targeting Brain Tumors in Texas
TX, US
Added 2 years ago
Biopharmaceuticals and Targeted Therapy Development
Development-stage biopharmaceutical company in Texas focused on a patented small-molecule therapy targeting brain tumors, with clinical trials scheduled to begin in the second half of 2024.
Key Information
Asking
–
Revenue
–
Earnings
–
Multiple
–
Key Highlights
- Development-stage biopharmaceutical company based in Texas
- Focuses on a novel, patented small-molecule therapeutic agent for brain cancers
- Therapeutic agent targets and inhibits a transcription factor highly expressed in glioblastomas and other brain tumors
- Preclinical efficacy demonstrated in tumor cell-based and animal models of glioblastoma
- Drug is orally available and achieves therapeutically relevant brain tissue concentrations in non-human primates
- Holds an open US IND with orphan drug designation, fast track designation, and rare pediatric disease designation
- Phase 1 clinical trials scheduled to begin in the second half of 2024
Contact Info
Unlock Premium Features
Get everything you need to find, finance, and acquire your business
Personalized Deal Flow
On and off market deals curated to your search criteria.
Unlimited 1:1 M&A Support
Expert advisors to help you spot red flags, negotiate your offer, and hand hold you all the way to close.
Pre-Vetted Deal Team
- * Intros to our preferred lenders
- * Access to our investor community
- * Discounted 3rd party Financial and Legal diligence